Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Updated: Dec 2 2021

Aromatase Inhibitors

  • Snapshot
    • A 59-year-old woman with recently diagnosed metastatic estrogen-receptor (ER) positive and human epidermal growth factor 2 (HER2) negative breast cancer presents for follow-up care. She is hormone therapy naive and has non-visceral involvement of the cancer. She is started on letrozole.
  • Introduction
    • Mechanism of action
      • inhibits peripheral conversion of androgens to estrogens via aromatase inhibition
    • Clinical use
      • estrogen-receptor positive breast cancer
        • first-line treatment in postmenopausal women to prevent recurrence
    • Toxicity
      • menopausal symptoms
      • fatigue
    • Medications
      • letrozole
      • anastrozole
      • exemestane
Card
1 of 0
Question
1 of 2
Private Note

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options